Charles Schwab’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52.7M Buy
1,013,272
+16,766
+2% +$873K 0.01% 1072
2025
Q1
$42.5M Sell
996,506
-20,027
-2% -$853K 0.01% 1185
2024
Q4
$31.1M Buy
1,016,533
+13,395
+1% +$409K 0.01% 1434
2024
Q3
$23M Sell
1,003,138
-306,293
-23% -$7.03M ﹤0.01% 1622
2024
Q2
$37.8M Buy
1,309,431
+32,332
+3% +$934K 0.01% 1265
2024
Q1
$26.3M Buy
1,277,099
+44,982
+4% +$928K 0.01% 1449
2023
Q4
$33.3M Buy
1,232,117
+20,618
+2% +$558K 0.01% 1270
2023
Q3
$35.9M Buy
1,211,499
+292,888
+32% +$8.68M 0.01% 1126
2023
Q2
$32.9M Buy
918,611
+312,875
+52% +$11.2M 0.01% 1163
2023
Q1
$14.2M Buy
605,736
+5,254
+0.9% +$123K ﹤0.01% 1698
2022
Q4
$16.3M Buy
600,482
+23,713
+4% +$645K 0.01% 1572
2022
Q3
$31M Buy
576,769
+8,084
+1% +$435K 0.01% 1073
2022
Q2
$22.9M Buy
568,685
+11,652
+2% +$470K 0.01% 1293
2022
Q1
$36.9M Buy
557,033
+12,600
+2% +$835K 0.01% 1083
2021
Q4
$54.5M Buy
544,433
+13,450
+3% +$1.35M 0.02% 837
2021
Q3
$66.4M Buy
530,983
+93,306
+21% +$11.7M 0.02% 702
2021
Q2
$54.4M Buy
437,677
+14,293
+3% +$1.78M 0.02% 802
2021
Q1
$64.6M Buy
423,384
+2,672
+0.6% +$408K 0.02% 674
2020
Q4
$54.2M Buy
420,712
+40,959
+11% +$5.28M 0.02% 733
2020
Q3
$42.4M Buy
379,753
+125,620
+49% +$14M 0.02% 739
2020
Q2
$20.6M Buy
254,133
+62,145
+32% +$5.04M 0.01% 1144
2020
Q1
$13.4M Buy
191,988
+17,998
+10% +$1.25M 0.01% 1273
2019
Q4
$13.6M Buy
173,990
+3,850
+2% +$301K 0.01% 1477
2019
Q3
$10.9M Buy
170,140
+24,214
+17% +$1.55M 0.01% 1557
2019
Q2
$12.6M Buy
145,926
+69,363
+91% +$5.99M 0.01% 1445
2019
Q1
$5.87M Buy
76,563
+2,465
+3% +$189K ﹤0.01% 1906
2018
Q4
$2.79M Buy
+74,098
New +$2.79M ﹤0.01% 2201